Bromocriptine mesylate and Rashes - a phase IV clinical study of FDA data

Summary:

Rashes is reported as a side effect among people who take Bromocriptine mesylate (bromocriptine mesylate), especially for people who are female, 60+ old, also take Synthroid, and have Gastritis.

The phase IV clinical study analyzes which people have Rashes when taking Bromocriptine mesylate. It is created by eHealthMe based on reports of 918 people who have side effects when taking Bromocriptine mesylate from the FDA, and is updated regularly.

What is Bromocriptine mesylate?

Bromocriptine mesylate has active ingredients of bromocriptine mesylate. It is often used in prolactinoma. eHealthMe is studying from 1,011 Bromocriptine mesylate users. Check the latest studies of Bromocriptine mesylate.

What is Rashes?

Rashes (redness) is found to be associated with 3,712 drugs and 6,212 conditions by eHealthMe. Check the latest studies of Rashes.

On Jul, 06, 2026

918 people reported to have side effects when taking Bromocriptine mesylate.
Among them, 15 people (1.63%) have Rashes.

Could Bromocriptine mesylate cause Rashes?

Among these 15 people:

What is the gender of people who have Rashes when taking Bromocriptine mesylate? *

female: 80 %
male: 20 %

What is the age of people who have Rashes when taking Bromocriptine mesylate? *

What are other drugs people take besides Bromocriptine mesylate? *

What are other side effects people have besides Rashes? *

Dyspnea (difficult or laboured breathing): 5 people, 33.33%
Swelling Face: 4 people, 26.67%
Itching: 3 people, 20.00%
Arteriospasm Coronary (spasm of the large- or medium-sized coronary arteries): 3 people, 20.00%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 3 people, 20.00%
Electrocardiogram T Wave Inversion: 3 people, 20.00%
Breast Engorgement (swelling of the breast): 3 people, 20.00%
Stress Cardiomyopathy (stress-induced chronic disease of the heart muscle): 3 people, 20.00%
Breast Infection: 3 people, 20.00%
Chest Pain: 3 people, 20.00%

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 1 person, 6.67%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 6.67%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 1 person, 6.67%
Back Pain: 1 person, 6.67%
Bipolar Disorder (mood disorder): 1 person, 6.67%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 6.67%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 6.67%
Constipation: 1 person, 6.67%
Depression: 1 person, 6.67%
Gastritis (inflammation of stomach): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Bromocriptine mesylate and have Rashes?

- Check whether Rashes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bromocriptine mesylate:

Bromocriptine mesylate (1,011 reports)

Rashes treatments and more:

Rashes (702,909 reports)

Browse all side effects of Bromocriptine mesylate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rashes:

Rashes (3,712 drugs)

Browse all the conditions that are associated with Rashes:

Rashes (6,212 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bromocriptine mesylate (the active ingredients of Bromocriptine mesylate) and Bromocriptine mesylate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.